Mark Throsby

Mark Throsby

Chief Executive Officer at
ATB Therapeutics
59 year
Health Technology
Consumer Services
Commercial Services

Profile

Mark Throsby is Chief Executive Officer at ATB Therapeutics SA since 2026.
Dr. Throsby is Chairman at Alethiomics Ltd. Dr. Throsby is Independent Director at Ona Therapeutics SL since 2021.
Dr. Throsby is Chief Operating & Scientific Officer at Gadeta BV since 2020.
Dr. Throsby was Director-Antibody Discovery at Crucell NV from 2000 to 2008.
Dr. Throsby was Chief Scientific Officer & Executive VP at Merus NV from 2013 to 2020.
Dr. Throsby earned a doctorate from Monash University.

Mark Throsby active positions

CompaniesPositionStart
Director/Board Member 05/03/2021
Chairman -
Chief Operating Officer 01/10/2020
Chief Executive Officer 13/05/2026

Former positions of Mark Throsby

CompaniesPositionEnd
MERUS N.V. Chief Operating Officer 01/01/2013
Corporate Officer/Principal 28/10/2008
See the detail of Mark Throsby's experience

Training of Mark Throsby

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

48

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies7

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services